Gabelli Global Small and Mid Cap Value (GGZ) vs Solana (HSDT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Gabelli Global Small and Mid Cap Value (GGZ) has outperformed Solana (HSDT) over the past year, gaining 5.2% versus a loss of 85.8%. Over five years, GGZ leads with a -6.0% price change compared with -100.0% for HSDT. Solana is the larger company by market cap ($155.6 million vs $114.8 million), about 1.4 times the size.
On valuation, Solana trades at a lower trailing P/E (0.0x vs 4.8x for Gabelli Global Small and Mid Cap Value).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GGZ | HSDT |
|---|---|---|
| Share price | $15.25 | $2.39 |
| Market cap | $114.84M | $155.60M |
| 1-day change | +1.40% | +0.42% |
| YTD return | +1.67% | -17.30% |
| 1-year return | +5.24% | -85.84% |
| 5-year return | -5.98% | -100.00% |
| P/E ratio (TTM) | 4.78 | 0.04 |
| EPS (TTM) | $3.19 | $53.74 |
| Dividend yield | 5.51% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $17.08 | $16.81 |
| 52-week low | $13.35 | $1.19 |
| Distance from 52-week high | -10.71% | -85.78% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +46.44% |
| Average volume | 6.26K | 357.83K |
| Shares outstanding | 7.53M | 65.10M |
| Employees | — | 21 |
| Sector | Finance | Health Care |
| Industry | Investment Managers | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- GGZ has outperformed HSDT by 91.1 percentage points over the past year.
- Gabelli Global Small and Mid Cap Value trades at a higher earnings multiple (4.8x vs 0.0x trailing P/E).
- Gabelli Global Small and Mid Cap Value offers a meaningfully higher dividend yield (5.51% vs 0.00%).
- The two companies sit in different sectors: Gabelli Global Small and Mid Cap Value in Finance and Solana in Health Care.
About Gabelli Global Small and Mid Cap Value
GGZ stock →The Gabelli Global Small and Mid Cap Value Trust is a closed-ended equity mutual fund launched by GAMCO Investors, Inc. The fund is managed by Gabelli Funds, LLC.
Finance · Investment Managers
About Solana
HSDT stock →Solana Company operates as a listed digital asset treasury. The company enhances Solana tokens per share on the commercially viable blockchain for decentralized finance and consumer applications.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 21 employees
GGZ vs HSDT FAQ
Which is bigger, Gabelli Global Small and Mid Cap Value or Solana?
Solana (HSDT) is larger, with a market capitalization of $155.60M compared with $114.84M for Gabelli Global Small and Mid Cap Value (GGZ).
Which stock has performed better over the past year, GGZ or HSDT?
GGZ returned +5.24% over the past 12 months, compared with -85.84% for HSDT (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, GGZ or HSDT?
HSDT has the lower trailing P/E at 0.0, versus 4.8 for GGZ. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Gabelli Global Small and Mid Cap Value or Solana?
Gabelli Global Small and Mid Cap Value pays a dividend yielding 5.51%, while Solana does not currently pay a regular dividend.
Are Gabelli Global Small and Mid Cap Value and Solana in the same industry?
No. Gabelli Global Small and Mid Cap Value is in the Finance sector, while Solana is in Health Care.